Zacks Investment Management Acquires 40,825 Shares of Colgate-Palmolive (NYSE:CL)

Zacks Investment Management boosted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 928.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,224 shares of the company's stock after acquiring an additional 40,825 shares during the quarter. Zacks Investment Management's holdings in Colgate-Palmolive were worth $4,695,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. RFG Advisory LLC grew its position in shares of Colgate-Palmolive by 2.1% during the 2nd quarter. RFG Advisory LLC now owns 5,411 shares of the company's stock worth $525,000 after purchasing an additional 112 shares in the last quarter. Occidental Asset Management LLC increased its position in Colgate-Palmolive by 7.7% during the 2nd quarter. Occidental Asset Management LLC now owns 2,860 shares of the company's stock worth $278,000 after purchasing an additional 205 shares in the last quarter. LVW Advisors LLC bought a new position in Colgate-Palmolive in the 2nd quarter valued at approximately $281,000. Sequoia Financial Advisors LLC grew its stake in shares of Colgate-Palmolive by 3.9% during the second quarter. Sequoia Financial Advisors LLC now owns 20,279 shares of the company's stock worth $1,968,000 after buying an additional 767 shares during the last quarter. Finally, Wedmont Private Capital increased its holdings in shares of Colgate-Palmolive by 17.4% during the second quarter. Wedmont Private Capital now owns 6,943 shares of the company's stock worth $681,000 after buying an additional 1,027 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Ratings Changes

CL has been the subject of several analyst reports. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a report on Monday, October 28th. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a report on Wednesday, September 4th. TD Cowen dropped their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their price target for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of "Moderate Buy" and a consensus price target of $105.11.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Stock Down 1.4 %

Colgate-Palmolive stock traded down $1.28 during trading hours on Monday, hitting $92.95. 4,933,593 shares of the stock traded hands, compared to its average volume of 4,385,129. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30. The company has a market cap of $75.94 billion, a PE ratio of 26.63, a PEG ratio of 3.36 and a beta of 0.43. The firm's 50-day moving average price is $96.33 and its two-hundred day moving average price is $98.65. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.15%. Colgate-Palmolive's payout ratio is currently 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.